col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


166 Ergebisse       Seite 1

 [1] 
Public Library of Science: PLoS Medicine
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mrz―11 Direct and indirect impacts of the COVID-19 pandemic on life expectancy and person-years of life lost with and without disability: A systematic analysis for 18 European countries, 2020-2022 Sara Ahmadi-Abhari, Piotr Bandosz, Martin J. Shipley, Joni V. Lindbohm, Abbas Dehghan, Paul Elliott, et al. (+2)
2 [GO] 2025―Jan―23 Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study Raphael S. Peter, Alexandra Nieters, Siri Göpel, Uta Merle, Jürgen M. Steinacker, Peter Deibert, et al. (+19)
3 [GO] 2025―Jan―23 Child mortality in England after national lockdowns for COVID-19: An analysis of childhood deaths, 2019-2023 David Odd, Sylvia Stoianova, Tom Williams, Peter Fleming, Karen Luyt, Lars Åke Persson
4 [GO] 2025―Jan―21 Estimating the impact of school closures on the COVID-19 dynamics in 74 countries: A modelling analysis Romain Ragonnet, Angus E. Hughes, David S. Shipman, Michael T. Meehan, Alec S. Henderson, Guillaume Briffoteaux, et al. (+5)
5 [GO] 2025―Jan―17 Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C Abhishek Bhatia, Alexander J. Preiss, Xuya Xiao, M. Daniel Brannock, G. Caleb Alexander, Robert F. Chew, et al. (+12)
6 [GO] 2024―Nov―26 Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study Frederick K. Ho, Caroline Dale, Mehrdad A. Mizani, Thomas Bolton, Ewan R. Pearson, Jonathan Valabhji, et al. (+15)
7 [GO] 2024―Sep―12 Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial William H. K. Schilling, Mavuto Mukaka, James J. Callery, Martin J. Llewelyn, Cintia V. Cruz, Mehul Dhorda, et al. (+82)
8 [GO] 2024―Jul―15 Deaths with COVID-19 and from all-causes following first-ever SARS-CoV-2 infection in individuals with preexisting mental disorders: A national cohort study from Czechia Tomáš Formánek, Libor Potočár, Katrin Wolfova, Hana Melicharová, Karolína Mladá, Anna Wiedemann, et al. (+6)
9 [GO] 2024―Jun―24 Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: An observational cohort study using the OpenSAFELY platform Miriam Samuel, Robin Y. Park, Sophie V. Eastwood, Fabiola Eto, Caroline E. Morton, Daniel Stow, et al. (+12)
10 [GO] 2024―Apr―17 Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub Sung-mok Jung, Sara L. Loo, Emily Howerton, Lucie Contamin, Claire P. Smith, Erica C. Carcelén, et al. (+54)
11 [GO] 2024―Apr―04 Long-term outcomes of hospitalized patients with SARS-CoV-2/COVID-19 with and without neurological involvement: 3-year follow-up assessment Anna Eligulashvili, Moshe Gordon, Jimmy S. Lee, Jeylin Lee, Shiv Mehrotra-Varma, Jai Mehrotra-Varma, et al. (+11)
12 [GO] 2024―Feb―20 Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in ethnic minorities: A nationwide register-linked cohort study in Denmark George Frederick Mkoma, Charles Agyemang, Thomas Benfield, Mikael Rostila, Agneta Cederström, Jørgen Holm Petersen, et al. (+2)
13 [GO] 2024―Jan―24 Mental health in the COVID-19 pandemic: A longitudinal analysis of the CLoCk cohort study Laura Panagi, Simon R. White, Snehal M. Pinto Pereira, Manjula D. Nugawela, Isobel Heyman, Kishan Sharma, et al. (+10)
14 [GO] 2023―Dez―07 Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial Judith Leblanc, Lisbeth Dusserre-Telmon, Anthony Chauvin, Tabassome Simon, Chiara E. Sabbatini, Karla Hemming, et al. (+16)
15 [GO] 2023―Nov―28 Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study Alexandra B. Hogan, Sean L. Wu, Jaspreet Toor, Daniela Olivera Mesa, Patrick Doohan, Oliver J. Watson, et al. (+8)
16 [GO] 2023―Sep―26 Evaluating socioeconomic inequalities in influenza vaccine uptake during the COVID-19 pandemic: A cohort study in Greater Manchester, England Ruth Elizabeth Watkinson, Richard Williams, Stephanie Gillibrand, Luke Munford, Matt Sutton, Rebecca F. Grais
17 [GO] 2023―Sep―08 Real-time surveillance of international SARS-CoV-2 prevalence using systematic traveller arrival screening: An observational study Adam J. Kucharski, Kiyojiken Chung, Maite Aubry, Iotefa Teiti, Anita Teissier, Vaea Richard, et al. (+4)
18 [GO] 2023―Jul―24 Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study Xi Xiong, David Tak Wai Lui, Matthew Shing Hin Chung, Ivan Chi Ho Au, Francisco Tsz Tsun Lai, Eric Yuk Fai Wan, et al. (+11)
19 [GO] 2023―Jul―19 Correction: Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study
20 [GO] 2023―Jun―29 Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, Weimin Liu, Regina M. Stoltz, Allisa K. Oman, et al. (+18)
21 [GO] 2023―Jun―14 Major trauma presentations and patient outcomes in English hospitals during the COVID-19 pandemic: An observational cohort study Carl Marincowitz, Omar Bouamra, Tim Coats, Dhushy Kumar, David Lockey, Lyndon Mason, et al. (+5)
22 [GO] 2023―Jun―07 Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England Julia Stowe, Elizabeth Miller, Nick Andrews, Heather J. Whitaker
23 [GO] 2023―Jun―05 Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study David R. M. Smith, George Shirreff, Laura Temime, Lulla Opatowski
24 [GO] 2023―Mai―18 SARS-CoV-2 transmission with and without mask wearing or air cleaners in schools in Switzerland: A modeling study of epidemiological, environmental, and molecular data Nicolas Banholzer, Kathrin Zürcher, Philipp Jent, Pascal Bittel, Lavinia Furrer, Matthias Egger, et al. (+3)
25 [GO] 2023―Apr―27 Home working and social and mental wellbeing at different stages of the COVID-19 pandemic in the UK: Evidence from 7 longitudinal population surveys Jacques Wels, Bożena Wielgoszewska, Bettina Moltrecht, Charlotte Booth, Michael J. Green, Olivia KL Hamilton, et al. (+17)
26 [GO] 2023―Apr―25 COVID-19 and common mental health symptoms in the early phase of the pandemic: An umbrella review of the evidence Anke B. Witteveen, Susanne Y. Young, Pim Cuijpers, José Luis Ayuso-Mateos, Corrado Barbui, Federico Bertolini, et al. (+14)
27 [GO] 2023―Apr―24 Depression and anxiety in people with cognitive impairment and dementia during the COVID-19 pandemic: Analysis of the English Longitudinal Study of Ageing Brian Beach, Andrew Steptoe, Paola Zaninotto, Lola Kola
28 [GO] 2023―Apr―24 Reimagining the journey to recovery: The COVID-19 pandemic and global mental health Vikram Patel, Daisy Fancourt, Toshi A. Furukawa, Lola Kola
29 [GO] 2023―Apr―18 Mental health and addiction health service use by physicians compared to non-physicians before and during the COVID-19 pandemic: A population-based cohort study in Ontario, Canada Daniel T. Myran, Rhiannon Roberts, Eric McArthur, Nivethika Jeyakumar, Jennifer M. Hensel, Claire Kendall, et al. (+7)
30 [GO] 2023―Apr―18 Investigating time-dependent COVID-19 pandemic mental health data: Challenges and opportunities of using panel data analysis Mariana Pinto da Costa, Robert Stewart
31 [GO] 2023―Apr―18 Depressive and anxiety symptoms in adults during the COVID-19 pandemic in England: A panel data analysis over 2 years Feifei Bu, Andrew Steptoe, Daisy Fancourt, Charlotte Hanlon
32 [GO] 2023―Apr―17 Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US Kin Wah Fung, Fitsum Baye, Seo H. Baik, Zhaonian Zheng, Clement J. McDonald
33 [GO] 2023―Apr―11 Mental disorders and COVID-19 deaths: Clinical, public health, and human rights implications Shekhar Saxena, Cindy Chwa
34 [GO] 2023―Apr―11 The COVID-19 pandemic and health-related quality of life across 13 high- and low-middle-income countries: A cross-sectional analysis Mara Violato, Jack Pollard, Andrew Lloyd, Laurence S. J. Roope, Raymond Duch, Matias Fuentes Becerra, et al. (+2)
35 [GO] 2023―Apr―06 COVID-19 and mental health: Building back better or reimagining a new way forward? Mark Tomlinson, Marguerite Marlow
36 [GO] 2023―Apr―06 COVID-19 and mental health in 8 low- and middle-income countries: A prospective cohort study Nursena Aksunger, Corey Vernot, Rebecca Littman, Maarten Voors, Niccolò F. Meriggi, Amanuel Abajobir, et al. (+18)
37 [GO] 2023―Apr―04 Long-term psychological distress trajectories and the COVID-19 pandemic in three British birth cohorts: A multi-cohort study Darío Moreno-Agostino, Helen L. Fisher, Alissa Goodman, Stephani L. Hatch, Craig Morgan, Marcus Richards, et al. (+3)
38 [GO] 2023―Apr―04 Multimorbidity: Addressing the next global pandemic
39 [GO] 2023―Feb―27 Comparison of new psychiatric diagnoses among Finnish children and adolescents before and during the COVID-19 pandemic: A nationwide register-based study David Gyllenberg, Kalpana Bastola, Wan Mohd Azam Wan Mohd Yunus, Kaisa Mishina, Emmi Liukko, Antti Kääriälä, et al. (+2)
40 [GO] 2023―Feb―21 Safety and effectiveness of monovalent COVID-19 mRNA vaccination and risk factors for hospitalisation caused by the omicron variant in 0.8 million adolescents: A nationwide cohort study in Sweden Peter Nordström, Marcel Ballin, Anna Nordström
41 [GO] 2023―Feb―14 Suicidal ideation following self-reported COVID-19-like symptoms or serology-confirmed SARS-CoV-2 infection in France: A propensity score weighted analysis from a cohort study Camille Davisse-Paturet, Massimiliano Orri, Stéphane Legleye, Aline-Marie Florence, Jean-Baptiste Hazo, Josiane Warszawski, et al. (+5)
42 [GO] 2023―Feb―06 Mental disorders, COVID-19-related life-saving measures and mortality in France: A nationwide cohort study Michaël Schwarzinger, Stéphane Luchini, Miriam Teschl, François Alla, Vincent Mallet, Jürgen Rehm, Vikram Patel
43 [GO] 2023―Jan―31 Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study Lance Turtle, Mathew Thorpe, Thomas M. Drake, Maaike Swets, Carlo Palmieri, Clark D. Russell, et al. (+13)
44 [GO] 2023―Jan―31 Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study Jacob Bor, Sabrina A. Assoumou, Kevin Lane, Yareliz Diaz, Bisola O. Ojikutu, Julia Raifman, Jonathan I. Levy
45 [GO] 2023―Jan―11 Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study Thiago Cerqueira-Silva, Syed Ahmar Shah, Chris Robertson, Mauro Sanchez, Srinivasa Vittal Katikireddi, Vinicius de Araujo Oliveira, et al. (+11)
46 [GO] 2023―Jan―10 Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study Jiayue Wan, Casey L. Cazer, Marin E. Clarkberg, Shane G. Henderson, Scarlett E. Lee, Genevive R. Meredith, et al. (+4)
47 [GO] 2023―Jan―06 Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study Kathryn S. Hensley, Marlou J. Jongkees, Daryl Geers, Corine H. GeurtsvanKessel, Yvonne M. Mueller, Virgil A. S. H. Dalm, et al. (+28)
48 [GO] 2022―Dez―20 Infection and transmission risks of COVID-19 in schools and their contribution to population infections in Germany: A retrospective observational study using nationwide and regional health and education agency notification data Torben Heinsohn, Berit Lange, Patrizio Vanella, Isti Rodiah, Stephan Glöckner, Alexander Joachim, et al. (+13)
49 [GO] 2022―Dez―01 Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case-control analysis Margaret L. Lind, Alexander J. Robertson, Julio Silva, Frederick Warner, Andreas C. Coppi, Nathan Price, et al. (+15)
50 [GO] 2022―Nov―22 Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Astrid Blicher Schelde, Mie Agermose Gram, Hanne-Dorthe Emborg, Jens Nielsen, et al. (+6)
51 [GO] 2022―Nov―10 Infection, immunity, and surveillance of COVID-19 Amitabh Bipin Suthar, Christopher Dye, Philippa Claire Dodd
52 [GO] 2022―Nov―10 Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany Martin Roessler, Falko Tesch, Manuel Batram, Josephine Jacob, Friedrich Loser, Oliver Weidinger, et al. (+28)
53 [GO] 2022―Nov―10 Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies Isabel Bergeri, Mairead G. Whelan, Harriet Ware, Lorenzo Subissi, Anthony Nardone, Hannah C. Lewis, et al. (+24)
54 [GO] 2022―Nov―09 Correction: Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study
55 [GO] 2022―Nov―08 COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study Marta Bertran, Zahin Amin-Chowdhury, Hannah G. Davies, Hester Allen, Tom Clare, Chloe Davison, et al. (+9)
56 [GO] 2022―Nov―07 Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study Baharak Babouee Flury, Sabine Güsewell, Thomas Egger, Onicio Leal, Angela Brucher, Eva Lemmenmeier, et al. (+17)
57 [GO] 2022―Okt―27 Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study Kathryn S. Hensley, Marlou J. Jongkees, Daryl Geers, Corine H. GeurtsvanKessel, Yvonne M. Mueller, Virgil A. S. H. Dalm, et al. (+29)
58 [GO] 2022―Okt―19 Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19 David M. Lowe, Li-An K. Brown, Kashfia Chowdhury, Stephanie Davey, Philip Yee, Felicia Ikeji, et al. (+11)
59 [GO] 2022―Sep―08 Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey Mariam O. Fofana, Nivison Nery, Juan P. Aguilar Ticona, Emilia M. M. de Andrade Belitardo, Renato Victoriano, Rôsangela O. Anjos, et al. (+16)
60 [GO] 2022―Sep―01 Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study Mie Agermose Gram, Hanne-Dorthe Emborg, Astrid Blicher Schelde, Nikolaj Ulrik Friis, Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, et al. (+12)
61 [GO] 2022―Aug―30 Healthcare utilization and maternal and child mortality during the COVID-19 pandemic in 18 low- and middle-income countries: An interrupted time-series analysis with mathematical modeling of administrative data Tashrik Ahmed, Timothy Roberton, Petra Vergeer, Peter M. Hansen, Michael A. Peters, Anthony Adofo Ofosu, et al. (+27)
62 [GO] 2022―Aug―26 Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study Ruud G. Nijman, Kate Honeyford, Ruth Farrugia, Katy Rose, Zsolt Bognar, Danilo Buonsenso, et al. (+41)
63 [GO] 2022―Aug―26 Quantifying inequities in COVID-19 vaccine distribution over time by social vulnerability, race and ethnicity, and location: A population-level analysis in St. Louis and Kansas City, Missouri Aaloke Mody, Cory Bradley, Salil Redkar, Branson Fox, Ingrid Eshun-Wilson, Matifadza G. Hlatshwayo, et al. (+10)
64 [GO] 2022―Aug―16 Universal healthcare coverage and health service delivery before and during the COVID-19 pandemic: A difference-in-difference study of childhood immunization coverage from 195 countries Sooyoung Kim, Tyler Y. Headley, Yesim Tozan, Margaret E. Kruk
65 [GO] 2022―Aug―10 Income differences in COVID-19 incidence and severity in Finland among people with foreign and native background: A population-based cohort study of individuals nested within households Sanni Saarinen, Heta Moustgaard, Hanna Remes, Riikka Sallinen, Pekka Martikainen, Aaloke Mody
66 [GO] 2022―Jul―28 Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study Marco Massari, Stefania Spila Alegiani, Cristina Morciano, Matteo Spuri, Pasquale Marchione, Patrizia Felicetti, et al. (+21)
67 [GO] 2022―Jul―28 Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study Inmaculada Hernandez, Sean Dickson, Shangbin Tang, Nico Gabriel, Lucas A. Berenbrok, Jingchuan Guo, Elvin Hsing Geng
68 [GO] 2022―Jul―19 Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK Emma Rezel-Potts, Abdel Douiri, Xiaohui Sun, Phillip J. Chowienczyk, Ajay M. Shah, Martin C. Gulliford, Weiping Jia
69 [GO] 2022―Jul―19 Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020 Natalie L. Cobb, Sigrid Collier, Engi F. Attia, Orvalho Augusto, T. Eoin West, Bradley H. Wagenaar, Mirjam E. E. Kretzschmar
70 [GO] 2022―Jun―27 Addressing the impacts of COVID-19 on refugee health Rebecca F. Grais, Emmanuel Baron
71 [GO] 2022―Jun―21 Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study Carlos King Ho Wong, Kristy Tsz Kwan Lau, Xi Xiong, Ivan Chi Ho Au, Francisco Tsz Tsun Lai, Eric Yuk Fai Wan, et al. (+8)
72 [GO] 2022―Mai―31 High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial Cédric Annweiler, Mélinda Beaudenon, Jennifer Gautier, Justine Gonsard, Sophie Boucher, Guillaume Chapelet, et al. (+12)
73 [GO] 2022―Mai―26 Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial Pengfei Jin, Xiling Guo, Wei Chen, Shihua Ma, Hongxing Pan, Lianpan Dai, et al. (+14)
74 [GO] 2022―Mai―26 Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis Christopher A. Martin, Daniel Pan, Carl Melbourne, Lucy Teece, Avinash Aujayeb, Rebecca F. Baggaley, et al. (+19)
75 [GO] 2022―Mai―26 Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis Diana Buitrago-Garcia, Aziz Mert Ipekci, Leonie Heron, Hira Imeri, Lucia Araujo-Chaveron, Ingrid Arevalo-Rodriguez, et al. (+15)
76 [GO] 2022―Mai―26 Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors Lukas E. Brümmer, Stephan Katzenschlager, Sean McGrath, Stephani Schmitz, Mary Gaeddert, Christian Erdmann, et al. (+12)
77 [GO] 2022―Mai―17 Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study Marit J. van Gils, Ayesha Lavell, Karlijn van der Straten, Brent Appelman, Ilja Bontjer, Meliawati Poniman, et al. (+21)
78 [GO] 2022―Mai―10 COVID-19 epidemiology and changes in health service utilization in Azraq and Zaatari refugee camps in Jordan: A retrospective cohort study Chiara Altare, Natalya Kostandova, Jennifer OKeeffe, Heba Hayek, Muhammad Fawad, Adam Musa Khalifa, et al. (+2)
79 [GO] 2022―Mai―10 Call for Papers: PLOS Medicine Special Issue on the COVID-19 Pandemic and Global Mental Health
80 [GO] 2022―Mai―04 Correction: COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness Carl A. B Pearson, Fiammetta Bozzani, Simon R. Procter, Nicholas G. Davies, Maryam Huda, Henning Tarp Jensen, et al. (+7)
81 [GO] 2022―Apr―22 Correction: Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study Ruth Elizabeth Watkinson, Richard Williams, Stephanie Gillibrand, Caroline Sanders, Matt Sutton
82 [GO] 2022―Apr―20 Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol Marina Wainstein, Samual MacDonald, Daniel Fryer, Kyle Young, Valeria Balan, Husna Begum, et al. (+16)
83 [GO] 2022―Mrz―03 Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study Ruth Elizabeth Watkinson, Richard Williams, Stephanie Gillibrand, Caroline Sanders, Matt Sutton, Mirjam E. E. Kretzschmar
84 [GO] 2022―Mrz―01 Changes in social contacts in England during the COVID-19 pandemic between March 2020 and March 2021 as measured by the CoMix survey: A repeated cross-sectional study Amy Gimma, James D. Munday, Kerry L. M. Wong, Pietro Coletti, Kevin van Zandvoort, Kiesha Prem, et al. (+6)
85 [GO] 2022―Mrz―01 Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study Corantin Maurin, Zhiguo He, Marielle Mentek, Paul Verhoeven, Sylvie Pillet, Thomas Bourlet, et al. (+14)
86 [GO] 2022―Feb―22 Vaccine equity: A fundamental imperative in the fight against COVID-19
87 [GO] 2022―Feb―22 Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data Fiona McQuaid, Rachel Mulholland, Yuma Sangpang Rai, Utkarsh Agrawal, Helen Bedford, J. Claire Cameron, et al. (+12)
88 [GO] 2022―Feb―22 Learning from the COVID-19 pandemic to strengthen routine immunization systems Kate Causey, Jonathan F. Mosser
89 [GO] 2022―Feb―22 First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales Steven Kerr, Mark Joy, Fatemeh Torabi, Stuart Bedston, Ashley Akbari, Utkarsh Agrawal, et al. (+29)
90 [GO] 2022―Feb―22 Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England William N. Whiteley, Samantha Ip, Jennifer A. Cooper, Thomas Bolton, Spencer Keene, Venexia Walker, et al. (+10)
91 [GO] 2022―Feb―15 Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study Evangelos Kontopantelis, Mamas A. Mamas, Roger T. Webb, Ana Castro, Martin K. Rutter, Chris P. Gale, et al. (+12)
92 [GO] 2022―Jan―28 COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination Ivan Gentile, Nicola Schiano Moriello
93 [GO] 2022―Jan―25 Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform Krishnan Bhaskaran, Christopher T. Rentsch, George Hickman, William J. Hulme, Anna Schultze, Helen J. Curtis, et al. (+27)
94 [GO] 2022―Jan―25 Pandemic health consequences: Grasping the long COVID tail Kieran L. Quinn, Chaim M. Bell
95 [GO] 2022―Jan―10 Obstetric interventions and pregnancy outcomes during the COVID-19 pandemic in England: A nationwide cohort study Ipek Gurol-Urganci, Lara Waite, Kirstin Webster, Jennifer Jardine, Fran Carroll, George Dunn, et al. (+7)
96 [GO] 2022―Jan―06 Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink Helen Strongman, Helena Carreira, Bianca L. De Stavola, Krishnan Bhaskaran, David A. Leon, Sanjay Basu
97 [GO] 2021―Dez―29 Correction: Social determinants of mortality from COVID-19: A simulation study using NHANES Benjamin Seligman, Maddalena Ferranna, David E. Bloom
98 [GO] 2021―Dez―20 Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study Jonathon W. Senefeld, Patrick W. Johnson, Katie L. Kunze, Evan M. Bloch, Noud van Helmond, Michael A. Golafshar, et al. (+53)
99 [GO] 2021―Dez―17 Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study Mie Agermose Gram, Jens Nielsen, Astrid Blicher Schelde, Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Anne Katrine Bjørkholt Sørensen, et al. (+3)
100 [GO] 2021―Dez―16 Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study Laith J. Abu-Raddad, Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, Joel A. Malek, Ayeda A. Ahmed, et al. (+19)
101 [GO] 2021―Dez―10 Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study Manoj V. Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, V. Saravanakumar, Muthusamy Santhosh Kumar, Sriram Selvaraju, et al. (+25)
102 [GO] 2021―Dez―09 SARS-CoV-2 vaccine boosters: The time to act is now Maya Petersen, Joshua Schwab, Diane V. Havlir
103 [GO] 2021―Dez―06 Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study Shelly Karuna, Shuying Sue Li, Shannon Grant, Stephen R. Walsh, Ian Frank, Martin Casapia, et al. (+10)
104 [GO] 2021―Nov―30 Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study Sylvie Epelboin, Julie Labrosse, Jacques De Mouzon, Patricia Fauque, Marie-José Gervoise-Boyer, Rachel Levy, et al. (+8)
105 [GO] 2021―Nov―29 COVID-19 in Africa: Catalyzing change for sustainable development Salim S. Abdool Karim, Segenet Kelemu, Cheryl Baxter
106 [GO] 2021―Nov―23 Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study Marije J. Splinter, Premysl Velek, M. Kamran Ikram, Brenda C. T. Kieboom, Robin P. Peeters, Patrick J. E. Bindels, et al. (+6)
107 [GO] 2021―Nov―05 SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study Christopher A. Martin, Colette Marshall, Prashanth Patel, Charles Goss, David R. Jenkins, Claire Ellwood, et al. (+6)
108 [GO] 2021―Okt―21 Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study George N. Ioannou, Jacqueline M. Ferguson, Ann M. O’Hare, Amy S. B. Bohnert, Lisa I. Backus, Edward J. Boyko, et al. (+9)
109 [GO] 2021―Okt―14 HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study Rita Bergqvist, Viktor H. Ahlqvist, Michael Lundberg, Maria-Pia Hergens, Johan Sundström, Max Bell, et al. (+2)
110 [GO] 2021―Okt―13 Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study Yin Mo, David W. Eyre, Sheila F. Lumley, Timothy M. Walker, Robert H. Shaw, Denise O’Donnell, et al. (+5)
111 [GO] 2021―Okt―13 Correction: Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis
112 [GO] 2021―Okt―12 Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial Simon Gilbody, Elizabeth Littlewood, Dean McMillan, Carolyn A. Chew-Graham, Della Bailey, Samantha Gascoyne, et al. (+20)
113 [GO] 2021―Okt―04 COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness Carl A. B. Pearson, Fiammetta Bozzani, Simon R. Procter, Nicholas G. Davies, Maryam Huda, Henning Tarp Jensen, et al. (+8)
114 [GO] 2021―Okt―01 COVID-19 and global equity for health: The good, the bad, and the wicked Elvin H. Geng, Michael J. A. Reid, Eric Goosby, Quarraisha Abdool-Karim
115 [GO] 2021―Okt―01 Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial Neil Formica, Raburn Mallory, Gary Albert, Michelle Robinson, Joyce S. Plested, Iksung Cho, et al. (+4)
116 [GO] 2021―Sep―28 Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people Joshua Elliott, Matthew Whitaker, Barbara Bodinier, Oliver Eales, Steven Riley, Helen Ward, et al. (+5)
117 [GO] 2021―Sep―28 Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 Maxime Taquet, Quentin Dercon, Sierra Luciano, John R. Geddes, Masud Husain, Paul J. Harrison, Mirjam E. E. Kretzschmar
118 [GO] 2021―Sep―13 Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed J Peter Figueroa, Peter J. Hotez, Carolina Batista, Yanis Ben Amor, Onder Ergonul, Sarah Gilbert, et al. (+15)
119 [GO] 2021―Aug―31 Building global health research capacity to address research imperatives following the COVID-19 pandemic Peter H. Kilmarx, Roger I. Glass
120 [GO] 2021―Aug―12 Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis Lukas E. Brümmer, Stephan Katzenschlager, Mary Gaeddert, Christian Erdmann, Stephani Schmitz, Marc Bota, et al. (+10)
121 [GO] 2021―Jul―13 Investigating associations between COVID-19 mortality and population-level health and socioeconomic indicators in the United States: A modeling study Sasikiran Kandula, Jeffrey Shaman, Richard Turner
122 [GO] 2021―Jul―06 Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study Shoya Iwanami, Keisuke Ejima, Kwang Su Kim, Koji Noshita, Yasuhisa Fujita, Taiga Miyazaki, et al. (+15)
123 [GO] 2021―Jul―06 SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, David Ross Darley, Deepti Pilli, Daniele Vitale, et al. (+23)
124 [GO] 2021―Jul―01 Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis Giorgia Sulis, Brice Batomen, Anita Kotwani, Madhukar Pai, Sumanth Gandra, Gwenan M. Knight
125 [GO] 2021―Jun―24 Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19 Wenhui Mao, Osondu Ogbuoji, David Watkins, Ipchita Bharali, Eric Boateng, Mohamed Mustafa Diab, et al. (+9)
126 [GO] 2021―Jun―23 COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control Seth C. Inzaule, Pascale Ondoa, Marguerite Massinga Loembe, Yenew Kebede Tebeje, Ahmed E Ogwell Ouma, John N. Nkengasong
127 [GO] 2021―Jun―07 Correction: Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic
128 [GO] 2021―Jun―01 Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study Guillaume Butler-Laporte, Tomoko Nakanishi, Vincent Mooser, David R. Morrison, Tala Abdullah, Olumide Adeleye, et al. (+11)
129 [GO] 2021―Mai―24 Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity Michel Goldman, Cédric Hermans
130 [GO] 2021―Mai―20 COVID-19 and excess mortality in the United States: A county-level analysis Andrew C. Stokes, Dielle J. Lundberg, Irma T. Elo, Katherine Hempstead, Jacob Bor, Samuel H. Preston, Amitabh Bipin Suthar
131 [GO] 2021―Apr―22 Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic Seye Abimbola, Sumegha Asthana, Cristian Montenegro Cortes, Renzo R. Guinto, Desmond Tanko Jumbam, Lance Louskieter, et al. (+7)
132 [GO] 2021―Mrz―11 How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities Michael Reid, Quarraisha Abdool-Karim, Elvin Geng, Eric Goosby
133 [GO] 2021―Mrz―04 Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis Aaron Leong, Joanne B. Cole, Laura N. Brenner, James B. Meigs, Jose C. Florez, Josep M. Mercader, Sébastien Theriault
134 [GO] 2021―Mrz―03 Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial María Elvira Balcells, Luis Rojas, Nicole Le Corre, Constanza Martínez-Valdebenito, María Elena Ceballos, Marcela Ferrés, et al. (+27)
135 [GO] 2021―Feb―04 Correction: Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study Mary T. Bassett, Jarvis T. Chen, Nancy Krieger
136 [GO] 2021―Jan―12 Social determinants of mortality from COVID-19: A simulation study using NHANES Benjamin Seligman, Maddalena Ferranna, David E. Bloom, Mirjam E. E. Kretzschmar
137 [GO] 2020―Dez―30 Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis Min Seo Kim, Min Ho An, Won Jun Kim, Tae-Ho Hwang, Mirjam E. E. Kretzschmar
138 [GO] 2020―Dez―29 Correction: Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
139 [GO] 2020―Dez―04 Correction: Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study
140 [GO] 2020―Okt―30 Acute kidney injury associated with COVID-19: A retrospective cohort study Nitin V. Kolhe, Richard J. Fluck, Nicholas M. Selby, Maarten W. Taal, Giuseppe Remuzzi
141 [GO] 2020―Okt―23 Correction: COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
142 [GO] 2020―Okt―20 Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study Paul M. McKeigue, Amanda Weir, Jen Bishop, Stuart J. McGurnaghan, Sharon Kennedy, David McAllister, et al. (+12)
143 [GO] 2020―Okt―20 Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study Mary T. Bassett, Jarvis T. Chen, Nancy Krieger, Alexander C. Tsai
144 [GO] 2020―Okt―06 Correction: Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest-posttest comparison group study Mark J. Siedner, Guy Harling, Zahra Reynolds, Rebecca F. Gilbert, Sebastien Haneuse, Atheendar S. Venkataramani, Alexander C. Tsai
145 [GO] 2020―Okt―01 Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study Janine Makaronidis, Jessica Mok, Nyaladzi Balogun, Cormac G. Magee, Rumana Z. Omar, Alisia Carnemolla, et al. (+2)
146 [GO] 2020―Sep―22 Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study Christopher T. Rentsch, Farah Kidwai-Khan, Janet P. Tate, Lesley S. Park, Joseph T. King, Melissa Skanderson, et al. (+11)
147 [GO] 2020―Sep―22 Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis Diana Buitrago-Garcia, Dianne Egli-Gany, Michel J. Counotte, Stefanie Hossmann, Hira Imeri, Aziz Mert Ipekci, et al. (+3)
148 [GO] 2020―Sep―17 Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project) Sophie Juul, Emil Eik Nielsen, Joshua Feinberg, Faiza Siddiqui, Caroline Kamp Jørgensen, Emily Barot, et al. (+9)
149 [GO] 2020―Sep―14 Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study Julia Stowe, Nick Andrews, Paul Gringras, Timothy Quinnell, Zenobia Zaiwalla, John Shneerson, et al. (+2)
150 [GO] 2020―Sep―10 Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis Stephanie L. Harrison, Elnara Fazio-Eynullayeva, Deirdre A. Lane, Paula Underhill, Gregory Y. H. Lip, Mirjam E. E. Kretzschmar
151 [GO] 2020―Sep―08 Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study Lars Christian Lund, Kasper Bruun Kristensen, Mette Reilev, Steffen Christensen, Reimar Wernich Thomsen, Christian Fynbo Christiansen, et al. (+6)
152 [GO] 2020―Sep―03 COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology Nicholas J. White, James A. Watson, Richard M. Hoglund, Xin Hui S. Chan, Phaik Yeong Cheah, Joel Tarning
153 [GO] 2020―Aug―28 The reimagination of school-based physical activity research in the COVID-19 era Deirdre M. Harrington, Michelle O’Reilly
154 [GO] 2020―Aug―11 Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest-posttest comparison group study Mark J. Siedner, Guy Harling, Zahra Reynolds, Rebecca F. Gilbert, Sebastien Haneuse, Atheendar S. Venkataramani, et al. (+2)
155 [GO] 2020―Jul―28 Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China Yan-Ting Wu, Jun Liu, Jing-Jing Xu, Yan-Fen Chen, Wen Yang, Yang Chen, et al. (+14)
156 [GO] 2020―Jul―28 Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe Anthony Hauser, Michel J. Counotte, Charles C. Margossian, Garyfallos Konstantinoudis, Nicola Low, Christian L. Althaus, et al. (+2)
157 [GO] 2020―Jul―21 Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study Alexandra Teslya, Thi Mui Pham, Noortje G. Godijk, Mirjam E. Kretzschmar, Martin C. J. Bootsma, Ganna Rozhnova, Yuming Guo
158 [GO] 2020―Jul―21 Can self-imposed prevention measures mitigate the COVID-19 epidemic? Lei Zhang, Yusha Tao, Mingwang Shen, Christopher K. Fairley, Yuming Guo
159 [GO] 2020―Jul―17 Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling study Francesco Pinotti, Laura Di Domenico, Ernesto Ortega, Marco Mancastroppa, Giulia Pullano, Eugenio Valdano, et al. (+4)
160 [GO] 2020―Jun―30 Will COVID-19 be evidence-based medicine’s nemesis? Trisha Greenhalgh
161 [GO] 2020―Jun―16 The potential impact of COVID-19 in refugee camps in Bangladesh and beyond:  A modeling study Shaun Truelove, Orit Abrahim, Chiara Altare, Stephen A. Lauer, Krya H. Grantz, Andrew S. Azman, et al. (+2)
162 [GO] 2020―Jun―16 Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series Che Zhang, Jiaowei Gu, Quanjing Chen, Na Deng, Jingfeng Li, Li Huang, et al. (+2)
163 [GO] 2020―Mai―29 Pandemic preparedness and responses: WHO to turn to in a crisis?
164 [GO] 2020―Mai―05 Antibody-based therapies for COVID-19: Can Europe move faster? Michel D. Kazatchkine, Michel Goldman, Jean-Louis Vincent
165 [GO] 2020―Apr―28 Pandemic responses: Planning to neutralize SARS-CoV-2 and prepare for future outbreaks
166 [GO] 2020―Jan―09 Infectious disease pandemic planning and response: Incorporating decision analysis Freya M. Shearer, Robert Moss, Jodie McVernon, Joshua V. Ross, James M. McCaw
 [1] 

166 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec